Variantyx Overview

  • Year Founded
  • 2014

Year Founded

  • Status
  • Private

  • Employees
  • 160

Employees

  • Latest Deal Type
  • Series D

  • Latest Deal Amount
  • $36M

  • Investors
  • 9

Variantyx General Information

Description

Developer of a whole genome analytical technology designed to diagnose and generate clinical reports for rare inherited disorders. The company's platform is based on published validation studies and accurately detects all clinically relevant variants from whole genome sequenced data, enabling hospitals and commercial labs to understand a patient's genetic makeup, resulting in accurate diagnosis and optimized treatment recommendations.

Contact Information

Ownership Status
Privately Held (backing)
Financing Status
Venture Capital-Backed
Primary Industry
Biotechnology
Other Industries
Drug Discovery
Laboratory Services (Healthcare)
Corporate Office
  • 1671 Worcester Road
  • Suite 400
  • Framingham, MA 01701
  • United States
+1 (617) 000-0000

Variantyx Timeline

2021202220232024
Financing RoundCaptured Employee CountEstimated Employee Growth

Want detailed data on 3M+ companies?

What you see here scratches the surface

Request a free trial

Want to dig into this profile?

We’ll help you find what you need

Learn more

Variantyx Valuation & Funding

Deal Type Date Amount Raised to Date Post-Val Status Stage
9. Later Stage VC (Series D) 26-Apr-2024 $36M 00000 0000 Completed Generating Revenue
8. Debt - General 18-Oct-2022 0000 0000 Completed Generating Revenue
7. Later Stage VC (Series C2) 14-Feb-2022 000.00 000.00 00000 Completed Generating Revenue
6. Later Stage VC (Series C) 15-Nov-2021 0000 000.00 0000 Completed Generating Revenue
5. Debt - PPP 02-May-2020 00000 000.00 Completed Generating Revenue
4. Secondary Transaction - Private 20-Mar-2020 000.00 Completed Generating Revenue
3. Later Stage VC 29-May-2019 000 000.00 0000 Completed Generating Revenue
2. Early Stage VC (Series A) 28-Dec-2018 $4.8M $4.8M 0000 Completed Startup
1. Spin-Off 01-Jan-2014 Completed Startup
To view Variantyx’s complete valuation and funding history, request access »

Variantyx Cap Table

Stock # of Shares
Authorized
Par Value Dividend Rate (%) Original
Issue Price
Liquidation Liquidation
Pref. Multiple
Conversion Price % Owned
Series D-2 00,000,000 00.000000 00.00 00.00 00 00.00 00.00
Series D-1 00,000,000 00.000000 00.00 00.00 00 00.00 00.000
Series D 00,000,000 00.000000 00.00 00.00 00 00.00 00.000
Series C-2 00,000,000 00.000000 00.00 00.00 00 00.00 0.000
Series C-1 0,000,000 00.000000 00.00 00.00 00 00.00 0.000
Series C 0,000,000 00.000000 00.00 00.00 00 00.00 0.000
Series B 6,206,645 $0.010000 $1.37 $1.37 1x $1.37 4.76%
Series A 3,709,246 $0.010000 $1.31 $1.31 1x $1.31 2.85%
To view Variantyx’s complete cap table history, request access »

Variantyx Comparisons

Description
Primary
Industry
HQ Location
Employees
Total Raised
Post Valuation
Last
Financing
Details
Developer of a whole genome analytical technology designed to diagnose and generate clinical reports for rare inherited
Biotechnology
Framingham, MA
160 As of 2024
00000
0000 0000-00-00
00000000000 00000

000000

d do eiusmod tempor incididunt ut labore et dolore magna aliqua. Ut enim ad mini
0000000000 00000000
Miami, FL
000 As of 0000
00.000 0000-00-00
000000&0

000000

prehenderit in voluptate velit esse cillum dolore eu fugiat nulla pariatur. Exce
0000000000000
Beijing, China
0000 As of 0000
00000
00000 0000-00-00
00000000 00000
Add Comparison

PitchBook’s comparison feature gives you a side-by-side look at key metrics for similar companies. Personalize which data points you want to see and create visualizations instantly.

Request a free trial

Variantyx Competitors (15)

Company Name Financing Status Location Employees Total Raised Last Financing Date/Type Last Financing Amount
Igenomix Formerly PE-Backed Miami, FL 000 000000&0
Novogene Formerly VC-backed Beijing, China 0000 00000 00000000 00000
Personal Genome Diagnostics Formerly VC-backed Baltimore, MD 000 00000 000000&0 00000
BGI Genomics Formerly VC-backed Shenzhen, China 0000 00000 000000000 00000
Caris Life Sciences Private Equity-Backed Irving, TX 0000 00.00 00000000000 00.00
You’re viewing 5 of 15 competitors. Get the full list »

Variantyx Executive Team (12)

Name Title Board Seat Contact Info
Haim Neerman Co-Founder, Chief Executive Officer & Board Member
Jeffrey Weisberg Chief Financial Officer
Yaron Rachmany Chief Operating Officer
Thomas DeLuca Chief Human Resources Officer
Tomer Jackman Co-Founder & Vice President of Customer Support & Laboratory Services
You’re viewing 5 of 12 executive team members. Get the full list »

Variantyx Board Members (8)

Name Representing Role Since
David Margulies MD Self Chairman 000 0000
Gideon Argov Self Board Member 000 0000
Haim Neerman Variantyx Co-Founder, Chief Executive Officer & Board Member 000 0000
Hila Karah Self Board Member 000 0000
Hillel Bachrach 20/20 HealthCare Partners Board Member 000 0000
You’re viewing 5 of 8 board members. Get the full list »

Variantyx Signals

Growth Rate

0.80% Weekly
Growth
Weekly Growth 0.80%, 93rd %
-35.5%. 530%

Size Multiple

219x Median
Size Multiple 219x, 100th %ile
0.00x 0.95x. 413Kx

Key Data Points

Twitter Followers

5.5k

Similarweb Unique Visitors

15.0K

Majestic Referring Domains

314

PitchBook’s non-financial metrics help you gauge a company’s traction and growth using web presence and social reach.

Request a free trial

Variantyx Investors (9)

Investor Name Investor Type Holding Investor Since Participating Rounds Contact Info
Peregrine Ventures Venture Capital Minority 000 0000 000000 0
Bosch Ventures Corporate Venture Capital Minority 000 0000 000000 0
GHS Investment Management (Canada) Company Corporation Minority 000 0000 000000 0
IBM Ventures Corporate Venture Capital Minority 000 0000 000000 0
Merative Other Minority 000 0000 000000 0
You’re viewing 5 of 9 investors. Get the full list »

Variantyx FAQs

  • When was Variantyx founded?

    Variantyx was founded in 2014.

  • Who is the founder of Variantyx?

    Haim Neerman, Tomer Jackman, and Noam Shomron Ph.D are the founders of Variantyx.

  • Who is the CEO of Variantyx?

    Haim Neerman is the CEO of Variantyx.

  • Where is Variantyx headquartered?

    Variantyx is headquartered in Framingham, MA.

  • What is the size of Variantyx?

    Variantyx has 160 total employees.

  • What industry is Variantyx in?

    Variantyx’s primary industry is Biotechnology.

  • Is Variantyx a private or public company?

    Variantyx is a Private company.

  • What is the current valuation of Variantyx?

    The current valuation of Variantyx is 0000.

  • What is Variantyx’s current revenue?

    The current revenue for Variantyx is 00000.

  • How much funding has Variantyx raised over time?

    Variantyx has raised $135M.

  • Who are Variantyx’s investors?

    Peregrine Ventures, Bosch Ventures, GHS Investment Management (Canada) Company, IBM Ventures, and Merative are 5 of 9 investors who have invested in Variantyx.

  • Who are Variantyx’s competitors?

    Igenomix, Novogene, Personal Genome Diagnostics, BGI Genomics, and Caris Life Sciences are some of the 15 competitors of Variantyx.

Data Transparency

  • Meet our data hygiene team

    Discover how our experts ensure you’re getting the most accurate financial data in the industry.

    Read blog »
  • How PitchBook sources data

    Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.

    Discover our process »